Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an intestinal infection with C. albicans in immunosuppressed mice. Orally administered ketoconazole was used a...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Troke, P F, Andrews, R J, Brammer, K W, Marriott, M S, Richardson, K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180335/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3002246/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.6.815
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!